In this twenty-first episode, Nichola Conlon provides a scientific background, introducing sirtuins and NAD. She then explains why popular NAD+ boosters, NR and NMN, are first-gen products. - Read the transcript -

In this twentieth episode, Polina Mamoshina introduces recently launched Deep Longevity, and its app (young.ai). - Read the transcript - Biomarkers of aging are introduced. She explains that they have taken a superior approach by using deep learning ...

In this nineteenth episode, Stephen Matlin introduces telomere biology. He details how testing services typically use Q-PCR which provides an average telomere length and why that doesn't really mean anything. - Read the transcript -

In this eighteenth episode, Alexis Shields explains that blood biomarkers may be obtained directly and the results used to reduce chance of future disease occurrence, as well as remedy any subclinical symptoms. - Read the transcript -

In this seventeenth episode, Gordon Lauc introduces glycobiology. He details GlycanAge®, the world’s first direct-to-consumer glycan-based product. - Read the transcript - He explains that it can quantify how well interventions (e.g.

In this sixteenth episode, Knut Wittkowski shares his expert view that lockdowns were not necessary. That he can’t figure out a single justification for extending them. That there is no “second wave”. - Read the transcript -

In this fifteenth episode, Liz Parrish shares her quest for radical life extension and details her two completed gene therapies. - Read the transcript - She describes the regenerative medical tourism available today for increased lifespan and costs.

In this fourteenth episode, Dr. William Davis shares his view that healthcare is not primarily concerned with our health. Instead it is concerned with profit, even at the expense of our health. - Read the transcript -

In this thirteenth episode, Tom Stubbs, Co-Founder/CEO of Chronomics starts with introducing epigenetics. He describes the technology and expertise that he's brought together to create the only company in the world advancing the forefront of epigenetic...

In this twelfth episode, Jeff Kaditz, Founder/CEO of Q Bio begins with coronavirus chat. He goes on to explain that most medical knowledge today is probably incorrect or heavily biased. That there’s almost nothing a doctor does that couldn’t have been ...